Meeting
2014 ASCO Annual Meeting
Survival outcomes of primary myelodysplastic syndrome in United States.
Authors
Guru Subramanian Guru Murthy
University of Arkansas for Medical Sciences, Little Rock, AR
Guru Subramanian Guru Murthy , Pooja Motwani , Yogesh Jethava , Laura Fulper Hutchins , Peter D. Emanuel , Ishwori Dhakal , Issam Makhoul , Jeannette Y. Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 7112)
DOI
10.1200/jco.2014.32.15_suppl.7112
Abstract #
7112
Poster Bd #
397
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The effects of pre-existing psychiatric disorders on gastric cancer survival.
First Author: Josephine Soddano
Poster
2017 ASCO Annual Meeting
Relationship of bone marrow blast (BMBL) response to overall survival (OS) in a multicenter study of rigosertib (Rigo) in patients (pts) with myelodysplastic syndrome (MDS) with excess blasts progressing on or after treatment with a hypomethylating agent (HMA).
First Author: Aref Al-Kali
Poster
2015 Genitourinary Cancers Symposium
Impact of dose-escalated radiation on overall survival in men with nonmetastatic prostate cancer.
First Author: Anusha Kalbasi
Poster
2024 ASCO Annual Meeting
Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis.
First Author: Vivek Podder